SCHEMBL4685114

SCHEMBL4685114

Cc1ccc(C(=O)NCCN2CCN(c3nc(Cc4ccc(F)cc4)ns3)CC2)cc1.O=C(NCCN1CCN(c2nc(Cc3ccc(Cl)cc3)ns2)CC1)c1cccc(F)c1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 8/20 0.46
DRD4 P21917 5/20 0.46
DRD2 P14416 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
MAPT P10636 2/20 0.46
CYP2D6 P10635 1/20 0.46
PMP22 Q01453 1/20 0.46
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
HTR1D P28221 1/20 0.43
ADRA1A P35348 1/20 0.43
HTR2B P41595 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2005080 0.93 DRD4 (0.49) HTR1ADRD4DRD2CYP1A2CYP3A4
SCHEMBL2007262 0.91 HTR1A (0.52) HTR1ADRD4DRD2CYP1A2CYP3A4
SCHEMBL2006888 0.90 HTR1A (0.50) HTR1ADRD4DRD2HTR1DADRA1A
SCHEMBL2005405 0.90 DRD2 (0.51) HTR1ADRD4DRD2ALDH1A1HTR1D
SCHEMBL2002301 0.86 HTR1A (0.49) HTR1ADRD4MAPTHSD17B10
SCHEMBL2005025 0.85 HTR1A (0.54) HTR1ADRD4DRD2CYP1A2CYP3A4
SCHEMBL2005541 0.85 HTR1A (0.52) HTR1ADRD4DRD2HTR1DADRA1A
SCHEMBL2007048 0.84 HTR1A (0.47) HTR1ADRD4DRD2
SCHEMBL3144358 0.84 GLS (0.50) HTR1ADRD4MAPTHSD17B10
SCHEMBL4687884 0.83 HTR1A (0.52) HTR1ADRD4DRD2HTR1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1981504-A2 THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES NV Remynd (BE) 2008-10-22 EP claimed
WO-2007090617-A2 THIADIAZOLE DERIVATIVES FOR THE TREATMENT OF NEURO DEGENERATIVE DISEASES NV REMYND (BE) 2007-08-16 WO claimed